Abstract Background Resistance of cholangiocarcinoma to chemotherapy is a major problem in cancer treatment. The mechanism of resistance is believed to involve phosphoinositide-3- kinase (PI3K)/Akt activation. Although the platinum-containing compound oxaliplatin has been extensively used in the treatment of several solid tumors. recent data regarding its use to treat cholangiocarcino... https://www.roomyroomers.shop/product-category/writing-desk-and-executive-table/